SCHEMBL9771127

SCHEMBL9771127

Cc1ccc(C(SCCNC(=S)NC(=O)c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
CYP2C9 P11712 2/20 0.57
POLB P06746 3/20 0.55
ALOX12 P18054 3/20 0.52
CCR6 P51684 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
HPGD P15428 1/20 0.50
CYP2C19 P33261 1/20 0.50
LMNA P02545 3/20 0.49
MAPT P10636 1/20 0.49
MITF O75030 1/20 0.48
ACHE P22303 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9771085 0.94 ALDH1A1 (0.58) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL9771230 0.89 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL9866486 0.84 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL9771035 0.78 SLC6A3 (0.46) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL12069271 0.77 ALDH1A1 (0.81) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL15328470 0.76 ALDH1A1 (0.78) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL9866470 0.75 CYP1A2 (0.43) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL9771140 0.75 EPHX2 (0.71) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL12069951 0.74 MEN1 (0.89) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL22429105 0.74 CCR6 (0.66) ALDH1A1MEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0302896-B1 N-(W-SUBSTITUTED ALKYL)-N'-[(IMIDAZOLE-4-YL)ALKYL]GUANIDINE CEDONA PHARMACEUTICALS B.V. (NL) 1991-08-14 EP disclosed
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
US-5010095-A Antiallergens, congestive heart failure CEDONA PHARMACEUTICALS B.V. (NL) 1991-04-23 US disclosed